Aeterna Zentaris Files May 2024 6-K Report

Ticker: CSCIF · Form: 6-K · Filed: Jun 10, 2024 · CIK: 1113423

Sentiment: neutral

Topics: disclosure, regulatory-filing

Related Tickers: AEZS

TL;DR

Aeterna Zentaris filed a 6-K for May, with a key announcement on June 3rd. Stay tuned for details.

AI Summary

Aeterna Zentaris Inc. filed a Form 6-K on June 10, 2024, reporting for the month of May 2024. The filing indicates that on June 3, 2024, the company made a significant announcement, though the specific details of this announcement are not fully provided in the excerpt. The company is incorporated in A6 and its fiscal year ends on December 31.

Why It Matters

This filing provides an update on Aeterna Zentaris's activities and disclosures for May 2024, which is important for investors to stay informed about the company's ongoing operations and any material events.

Risk Assessment

Risk Level: medium — Form 6-K filings often contain updates that can impact a company's stock price, and the lack of specific detail in the provided excerpt necessitates caution.

Key Players & Entities

FAQ

What was the specific announcement made by Aeterna Zentaris on June 3, 2024?

The provided excerpt of the 6-K filing mentions that an announcement was made on June 3, 2024, but does not specify its content.

What is the reporting period for this Form 6-K filing?

The Form 6-K is for the month of May 2024.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed on June 10, 2024.

What is Aeterna Zentaris Inc.'s fiscal year end?

Aeterna Zentaris Inc.'s fiscal year ends on December 31.

Where is Aeterna Zentaris Inc.'s principal executive office located?

The principal executive office is located at c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7.

Filing Stats: 1,741 words · 7 min read · ~6 pages · Grade level 14.1 · Accepted 2024-06-10 13:31:28

Filing Documents

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38064 Aeterna Zentaris Inc. (Translation of registrant’s name into English) c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Explanatory Note On June 3, 2024, Aeterna Zentaris Inc. (“Aeterna”, “we”, “our” or the “Company”) and Ceapro Inc. (“Ceapro”) closed the previously announced business combination transaction (the “Arrangement”) pursuant to the Arrangement Agreement, dated as of December 13, 2023 (as amended by the Amendment Agreement, dated January 16, 2024, and as may be further amended, supplemented or otherwise modified from time to time, the “Arrangement Agreement”). Pursuant to the Arrangement Agreement, at the effective time of the Arrangement (the “Effective Time”), Aeterna acquired all of the issued and outstanding common shares in the capital of Ceapro in a company-approved Plan of Arrangement (the “Plan of Arrangement”) under the Canada Business Corporations Act such that at the Effective Time Ceapro became a wholly-owned subsidiary of Aeterna. Aeterna will continue the operations of Aeterna and Ceapro on a combined basis. In connection with the closing of the Arrangement, Aeterna issued a news release on June 3, 2024, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Also on June 3, 2024, Aeterna filed with the Canadian Securities Regulatory Authorities on SEDAR+ a material change report relating to the closing of the Arrangement, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference. On the same date, Aeterna also filed on SEDAR+ the executed Warrant Agreement, dated as of May 31, 2024, between Aeterna and Computershare Trust Company of Canada, governing the terms of the common share purchase warrants issued in accordance with the Plan of Arrangement, a copy of which is attached hereto as Exhibit 99.3 and is incorporated herein by reference. On the same date, Aeterna also filed on SEDAR+ its report on modern slavery pursuant to the Fighting Against Forced Labour and Child Labour in Supply Chains Act for the financial year ended December 31, 2023, a copy of which is attached hereto as Exhibit 99.4 and is incorporated herein by reference. On May 29, 2024, Aeterna issued a news release announcing that it had applied to extend the date for its annual meeting of shareholders. A copy of the news release is attached hereto as Exhibit 99.5 and is incorporated herein by reference. On June 3, 2024, Aeterna issued a Notice of Meeting and Record Date to NASDAQ and to Canadian Securities Regulatory Authorities. Copies of the Notices of Meeting and Record Date are attached hereto as Exhibits 99.6 and 99.7 and are incorporated herein by reference. Exhibit 99.1 included with this Report on Form 6-K is hereby incorporated by reference into Aeterna’s Registration Statements on Forms S-8 (No. 333-224737, No. 333-210561, No. 333-200834 and No. 333-279844) and Form F-3 (No. 333-254680) (collectively, the “Registration Statements”) and shall be deemed to be a part thereof from the date on which this Report on Form 6-K is furnished, to the extent not superseded by documents or reports subsequently filed or furnished. The information contained on any websites referenced in Exhibit 99.1 included with this Report on Form 6-K is not incorporated by reference or deemed to be a part of this Report on Form 6-K or any of the Registration Statements. Aeterna has filed a Registration Statement on Form F-1 (including a prospectus) (File No. 333-277115) (the “Form F-1 Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) for the issuance of common share purchase warrants and Common Shares issuable upon exercise thereof in connection with the Plan of Arrangement. Before you invest in any Common Shares, you should read the prospectus in the Form F-1 Registration Statement and the other documents incorporated by reference therein for more complete information about Aeterna, Ceapro, the Arrangement and the common share purchase warrant offering. You may get copies of the Form F-1 Registration Statement for free by visiting EDGAR on th

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing